Navigation Links
Accumed Research Associates Launches Official Website
Date:3/31/2010 Aims to Increase Local Enrollment of Medical Clinical Trials

(PRWEB) March 29, 2010 -- In a move aimed at reaching out to a larger local patient population, leading clinical trial and patient care site Accumed Research Associates of Garden City, NY on long Island has launched its official website.

The website,, provides comprehensive information on all of the clinical trials conducted at the company’s Garden City, New York site on Long Island. The company conducts clinical trials or research studies to test the effects and safety of new investigational medications, medical treatments, or devices on patients with various clinical conditions.

Speaking about what motivated Accumed Research to build a presence on the World Wide Web, founder of the company Dr. Mitchell D. Efros, M.D., FACS, said, “We want people to know that there are some excellent options available for treatment of various conditions that might not be available to most patients whose doctors do not have the availability or access to clinical trials. Clinical trials afford us the opportunity to remain on the cutting edge of new technologies and treatments and offer this to our patients.” Dr Efros continued, “In many instances the patients receive their study related care and medication for free and are compensated for their time and travel as well. Our patients receive safe and compassionate care and we want people to know about these options."

Accumed Research is currently conducting clinical research study on several urologic conditions including enlarged prostate (BPH), incontinence or urinary urgency incontinence, overactive bladder (OAB), nocturia, erectile dysfunction, and cancer of prostate and bladder.

The NY clinical trial company was founded by Dr Efros in 2001. He is the Medical Director and Principal Investigator at Accumed Research Associates. Dr Efros, who graduated with honors from the New York Medical College in 1982, has vast experience in all areas of urology. A well-respected figure in the field of clinical research, Dr Efros has been a principal investigator in more than100 clinical trials. The company also has five affiliated full-time board certified urologists conducting trials, and assisting them are two nurse practitioners and a physician assistant, whom have many years of combined research experience.

Dr. Efros and Accumed Research Associates are affiliated with the following prestigious research and medical organizations: Association of Clinical Research Professionals, Fellow of American College of Surgeons, American Urologic Association and American Association of Clinical Urologists.

About Accumed Research Associates (
Accumed Research Associates ( is located in Garden City, NY on Long Island, and is a leader in clinical trials and studies. With more than nine years of experience in all phases of urologic clinical research, Accumed Research Associates has access to a large research database and can prospectively identify suitable candidates for their clinical studies. The company’s strength includes its extensively trained employees dedicated to the highest standards of patient care as well as a state-of-the-art comprehensive facility, and research department.

Contact: Accumed Research Associates:
Tel: 1-888-746-2190
Email: Info(at)AccumedResearch(dot)com


Read the full story at

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Related medicine news :

1. McMaster researcher leads development of promising drug for inflammation
2. European hematologist receives award to conduct research in US
3. Research shows why we forget to take our medicine, and what we can do about it
4. New Research Shows 'Kangaroo Mother Care' Reduces Newborn Deaths More than 50 Percent
5. Researchers identify potential new target for treating hepatitis C
6. Canadian research team awarded international grant for work on Indigenous peoples health
7. New ethical guidelines needed for dementia research
8. Sisters Helping Sisters: A New Lupus Research Study to Follow Sisters of Lupus Patients
9. Research confirms that some forms of massage help against low-back pain
10. Aderans Research Acquires Intercytex Assets
11. Researchers Identify 2 Genes Linked to Fatty Liver Disease
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... “While riding the bus, I ... Bronx, N.Y. “I thought there had to be a convenient and comfortable way to ... The PROTECTOR enables disabled individuals to safely travel during cold or inclement weather. In ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible for advancing care ... disease. The Periwinkle Pioneers, nominated by the public, will receive special recognition throughout ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... philanthropic seniors, is resulting in a way for homeless people to have a ... have launched a new initiative whereby they are repurposing plastic bags into sleeping ...
(Date:11/25/2015)... ... November 25, 2015 , ... Since its launch in 2012, ... adult stem cell therapies to patients with chronic degenerative medical conditions. Now, the ... Registered Trademark (RTM). , Organizations are required to hold a registered trademark in ...
(Date:11/24/2015)... ... November 25, 2015 , ... Genesis Chiropractic Software ... software creates an agreement between the practice owner and the patient that automatically ... notification, and projections. Click here to learn more. , ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... FRANCISCO , Nov. 24, 2015  Thanks to ... Dignity Health St. Mary,s Medical Center,s Sister Diane Grassilli ... breast imaging capabilities in San Francisco ... an anonymous friend, stepped forward with a gift of ... for Breast Digital Mammography with Tomosynthesis and Whole Breast ...
(Date:11/24/2015)... Colo. , Nov. 24, 2015  Array ... that its Chief Executive Officer, Ron Squarer ... Healthcare Conference in New York.  The public is ... webcast on the Array BioPharma website.Event:Piper Jaffray Annual ... , Wednesday, December 2, 2015Time:1:30 p.m. Eastern Time ...
(Date:11/24/2015)... HOUSTON, TX and VANCOUVER, Nov. 24, 2015 /PRNewswire/ ... EPI; NASDAQ: EPIX ) announced today that the ... clinical study of EPI-506 as a treatment for metastatic ... States and Canada.  --> ... --> In the Phase 1/2 clinical trial, ...
Breaking Medicine Technology: